LABCORP HOLDINGS INC.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (dollars and shares in millions, except per share data)
During the three months ended June 30, 2026, the Company repurchased the following shares of its Common Stock:
| Total Number of Shares Repurchased | Average Price Paid Per Share | Total Number of Shares Repurchased as Part of Publicly Announced Program | Maximum Dollar Value of Shares that May Yet Be Repurchased Under the Program | |
|---|---|---|---|---|
| April 1 - April 30 | 0.3 | $267.94 | 0.3 | $655.9 |
| May 1 - May 31 | 0.6 | $256.19 | 0.6 | $503.6 |
| June 1 - June 30 | 0.4 | $260.85 | 0.4 | $378.6 |
| 1.3 | $260.30 | 1.3 |
At June 30, 2026, the Company had outstanding authorization from its Board to purchase up to $378.6 maximum value of shares of Common Stock. On July 8, 2026, the Board authorized the repurchase of an additional $1,000.0 in the maximum value of the Company’s shares of Common Stock as part of the Company’s ongoing share repurchase program, bringing the total share repurchase authorization to $1,378.6 maximum value of shares of Common Stock. The repurchase authorization has no expiration date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.